Search clinical trials for: Gastroenterology

Total 2259 results

Bristol-Myers Squibb

Completed

Study of Daclatasvir (BMS-790052) Add-on to Standard of Care in Treatment- naïve Patients (HEPCAT)

Hepatitis C Virus

Australia, Sweden, United States, Canada, France, Germany, Denmark, Mexico, Italy, Puerto Rico, Egypt
Queen's University

Terminated

Evaluation of Fecal Calprotectin Screening and a Gastroenterology Questionnaire for Triaging Children With Chronic Abdominal Pain and/or Diarrhea Referred to a Pediatric Gastroenterology Service

Chronic Diarrhea | Chronic Abdominal Pain

Canada
Shandong University

Unknown

Lower Fluorescein Sodium Dose on Confocal Laser Endoscopy Image Quality and Yellow Discoloration of the Skin

Image Quality | Skin Discoloration

China
Ferring Pharmaceuticals

Terminated

Efficacy and Safety Trial of Elobixibat in Patients With Chronic Idiopathic Constipation

Chronic Idiopathic Constipation

Sweden, Canada, Hungary, United States, Brazil, South Africa, Czech Republic, Germany, Mexico, Poland, Slovakia, United Kingdom
Ferring Pharmaceuticals

Terminated

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Chronic Idiopathic Constipation

Israel, Belgium, United States, United Kingdom, Germany, Poland, Brazil, Canada, Czech Republic, South Africa
Bristol-Myers Squibb

Completed

BMS-790052 (Daclatasvir) Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C

Hepatitis C

United States, Puerto Rico
Bristol-Myers Squibb

Completed

Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C

Hepatitis C

France, United Kingdom, Spain, United States, Italy, Puerto Rico, Greece
Bristol-Myers Squibb

Completed

Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment (HEPCAT)

Hepatitis C Virus

Australia, France, Mexico, United States, Canada, Germany, Denmark, Italy, Puerto Rico, Sweden, Argentina
Bristol-Myers Squibb

Completed

Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease

Crohn's Disease

Poland, United States, France, Belgium, Israel, Hungary, South Africa, Puerto Rico
Bristol-Myers Squibb

Completed

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen (LIRA-B)

Hepatitis B Virus

Australia, France, Germany, Korea, Republic of, Taiwan, United States, Canada, Italy, Netherlands, Singapore, Hong Kong
Bristol-Myers Squibb

Completed

UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 Infection in Subjects With Compensated Cirrhosis

Hepatitis C

United States, Australia, Canada, France
Bristol-Myers Squibb

Completed

Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care

Chronic Hepatitis C

France, United States, Puerto Rico
Bristol-Myers Squibb

Completed

Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials) (Hallmark QUAD)

Hepatitis C Virus

United States, Germany, Italy, Korea, Republic of, Sweden, Russian Federation, Canada, France, Argentina, Switzerland, Denmark, Taiwan, Netherlands, Spain, Mexico
Bristol-Myers Squibb

Completed

Ph IIA Study (SOC +/- NS5B) (HEPCAT)

Hepatitis C Virus

United States
Menarini Group

Completed

Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D) (IRIS-2)

Irritable Bowel Syndrome With Diarrhea

Poland, Germany, Spain, Denmark, Bulgaria, Czech Republic, Italy, Sweden
Shandong University

Unknown

Microbiota Community of Irritable Bowel Syndrome in Episodes and Remission Phase

Irritable Bowel Syndrome

China
Bristol-Myers Squibb

Completed

Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV (ALLY 3)

Hepatitis C

United States, Puerto Rico
Shandong University

Unknown

Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome

Irritable Bowel Syndrome

China
Centre Hospitalier Universitaire de Nice
Fondation de l'Avenir

Unknown

Effects of the Soluble Mediators of Mastocytes on the Intestinal Epithelial Barrier and of the Enteric Nervous System During the Syndrome of the Irritable Bowel

Irritable Bowel Syndrome

France
University Hospital, Basel, Switzerland

Completed

Intestinal Microbiota in Patients Before and After Bariatric Surgery and Healthy Controls

Obesity

Switzerland
Medical University of Vienna

Unknown

Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver Cirrhosis

Erectile Dysfunction | Cirrhosis

Austria
Medical University of Vienna

Completed

Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis

Cirrhosis | Portal Hypertension

Austria
University Hospital Inselspital, Berne
University of Colorado, Denver; Mayo Clinic; Northwestern University; University... and other collaborators

Unknown

Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index (EEsAI)

Deglutition Disorders | Esophageal Diseases | Eosinophilia

United States, Canada, Switzerland, United Kingdom
Asian Institute of Gastroenterology, India

Completed

Evaluation of Efficacy of Combination of Pregabalin and Antioxidant in Reducing Pain in Chronic Pancreatitis: a Randomized Control Trial

Chronic Pancreatitis

India
Kyoto University

Completed

Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis C

Hepatitis C, Chronic

Japan
Kyoto University

Completed

Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCC

Hepatitis C, Chronic

Japan
Karolinska University Hospital
Bengt Isaksson; Jansson, Anders, M.D.

Completed

Waterjet Versus Ultrasound Dissection During Hepatic Transection

Liver Tumour

Sweden
Taipei Veterans General Hospital, Taiwan
Taipei Medical University Hospital

Unknown

Prophylactic Antibiotics Before RFA for HCC

Hepatocellular Carcinoma

Taiwan
Light Sciences Oncology

Completed

Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases

Neoplasm Metastasis | Colorectal Neoplasms | Liver Metastases | Neoplasm Recurrence, Local

Sweden, India, Austria, Serbia, Germany, Romania, Croatia, Bosnia and Herzegovina, Italy, Latvia, Poland, Russian Federation, Ukraine
Herlev Hospital

Completed

Mesh Fixation With Intraperitoneal Tisseel (MEFIXIT)

Postoperative Pain | Ventral Hernia

Denmark
Lorenzo Camellini

Completed

Gastrostomy Tube Placed After Gastropexy Versus Gastrostomy Tube Placed Using the Traditional Push/Pull Techniques

Gastrostomy, Methods

Italy
Shandong University

Unknown

I-scan With Magnification for the Detection of Gastric Intestinal Metaplasia

Gastric Intestinal Metaplasia

China
Karolinska University Hospital

Unknown

Usefulness of Chromoendoscopy in Diagnosing Microscopic Colitis

Lymphocytic Colitis | Collagenous Colitis | Chronic Diarrhoea

Sweden
Epigenomics, Inc

Completed

Head to Head Study Epi proColon and FIT

Colorectal Cancer

United States, Puerto Rico
Shandong University

Unknown

The Expression of the Ionotropic Glutamate Receptors in Colon of IBS

Irritable Bowel Syndrome

China
Mahidol University

Completed

Efficacy of Wireless Capsule Endoscopy and CT Enterography in Obscure Gastrointestinal Bleeding

Gastrointestinal Bleeding

Thailand
Medical University of Vienna

Completed

Endomicroscopy and Gastric MALT-lymphoma

MALT-lymphoma

Austria
University Hospital, Lille

Completed

Esophageal Atresia: Metaplasia, Barrett (Oesophagix)

Gastroesophageal Reflux | Esophagus, Barrett

France, Belgium, Canada, Luxembourg
Gilead Sciences

Completed

Observational Study on Prevalence of Host and Viral Genotypes in Chronic Hepatitis B and Hepatitis C Patients in India

Hepatitis B | Hepatitis C

India
University of Aarhus

Unknown

Mapping of Metabolic Liver Functions in Patients With Non-alcoholic Fatty Liver Disease

Non-alcoholic Fatty Liver Disease

Denmark
Shandong University

Completed

Association Between Confocal Laser Endomicroscopic (CLE) Features and Colorectal Mucosal Microbiome

Hyperplasia | Colorectal Neoplasia | Mucosal Microbiome | Colorectal Inflammation

China
Warner Chilcott

Completed

Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis

Ulcerative Colitis

United States, Canada, Puerto Rico
Radboud University Medical Center
Novartis

Completed

Everolimus and LongActing Octreotide Trial in Polycystic Livers (ELATE)

Polycystic Liver Disease

Netherlands
Bristol-Myers Squibb

Completed

Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis

Colitis, Ulcerative

Australia, United States, Canada, France, Mexico, Austria, Italy, Netherlands, Belgium, Germany, Brazil, Hungary, South Africa, Poland
D-Pharm Ltd.

Terminated

DP-b99 in the Treatment of Acute High-risk Pancreatitis

Pancreatitis

Czech Republic
AstraZeneca
Nektar Therapeutics

Completed

A Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients With Opioid-Induced Constipation (OIC)

Opioid Induced Constipation (OIC)

United States
Tsumura USA
Syneos Health

Terminated

A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease

Crohn's Disease

United States
Shandong University

Unknown

Gastric Barrier Dysfunction of Functional Dyspepsia and Therapeutic Response to Puyuanhewei Detected by Endomicroscopy

Dyspepsia

China
Temple University
American College of Gastroenterology

Completed

Placebo Controlled Trial of Botulinum Toxin for Gastroparesis

Gastroparesis

United States
R.P.Herrmann
The Alfred; The Queen Elizabeth Hospital; Concord Hospital; Sir Charles Gairdner...

Completed

An Australian Study of Mesenchymal Stromal Cells for Crohn's Disease

Crohn Disease

Australia

Search clinical trials for: Gastroenterology

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations